Processa Pharmaceuticals, Inc. Banner Image

Processa Pharmaceuticals, Inc.

  • Ticker PCSA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Processa Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Hanover, Maryland
Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy (NGC) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvalsMore, Processa not only will be providing better therapy options to cancer patients but also increase the probability of FDA approval for its Next Generation Chemotherapy (NGC) drugs following an efficient path to approval.
Processa Pharmaceuticals, Inc.

Most Recent Annual Report

Processa Pharmaceuticals, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Processa Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!